In a filing, PTC Therapeutics Inc revealed its EXEC. VP AND CLO Boulding Mark Elliott unloaded Company’s shares for reported $89081.0 on May 15 ’25. In the deal valued at $46.18 per share,1,929 shares were sold. As a result of this transaction, Boulding Mark Elliott now holds 103,901 shares worth roughly $4.99 million.
Then, Boulding Mark Elliott sold 883 shares, generating $40,636 in total proceeds. Upon selling the shares at $46.02, the EXEC. VP AND CLO now owns 103,901 shares.
Before that, Boulding Mark Elliott bought 883 shares. PTC Therapeutics Inc shares valued at $40,640 were divested by the Officer at a price of $46.02 per share.
Truist initiated its PTC Therapeutics Inc [PTCT] rating to a Buy in a research note published on June 17, 2025; the price target was $80. A number of analysts have revised their coverage, including BofA Securities’s analysts, who increased its forecast for the stock in early May from “a Neutral” to “a Buy”. Citigroup also remained covering PTCT and has increased its forecast on May 07, 2025 with a “Neutral” recommendation from previously “Sell” rating. BofA Securities revised its rating on March 11, 2025. It rated PTCT as “a Neutral” which previously was an “an Underperform”.
Price Performance Review of PTCT
On Monday, PTC Therapeutics Inc [NASDAQ:PTCT] saw its stock fall -2.22% to $47.98. Over the last five days, the stock has lost -3.73%. PTC Therapeutics Inc shares have risen nearly 57.88% since the year began. Nevertheless, the stocks have risen 6.29% over the past one year. While a 52-week high of $58.38 was reached on 03/17/25, a 52-week low of $29.01 was recorded on 05/06/25.
Levels Of Support And Resistance For PTCT Stock
The 24-hour chart illustrates a support level at 47.20, which if violated will result in even more drops to 46.43. On the upside, there is a resistance level at 48.95. A further resistance level may holdings at 49.93.
How much short interest is there in PTC Therapeutics Inc?
A steep rise in short interest was recorded in PTC Therapeutics Inc stocks on 2025-06-13, dropping by 93486.0 shares to a total of 5.07 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 5.17 million shares. There was a decline of -1.84%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 07, 2025 when Scotiabank began covering the stock and recommended ‘”a Sector perform”‘ rating along with a $55 price target.
